Duncan Moore

Insider Reports History

Location
Washington, Dc, DC
Signature
/s/ Donald Ainscow, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Duncan Moore:

Company Role Class Num Shares Value Price $ Report Date Ownership
ASP Isotopes Inc. Director Common Stock 994,553 $9,232,534 $9.28 29 Aug 2025 Direct
Allarity Therapeutics, Inc. Director Common Stock, $0.0001 22,672 20 Dec 2021 Direct

Insider Reports Filed by Duncan Moore

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ASPI ASP Isotopes Inc. 29 Aug 2025 1 -$696,232 4 Director 03 Sep 2025, 17:40
ASPI ASP Isotopes Inc. 09 Dec 2024 2 $0 4 Director 11 Dec 2024, 20:58
ASPI ASP Isotopes Inc. 20 Nov 2024 1 $0 4 Director 21 Nov 2024, 19:34
ASPI ASP Isotopes Inc. 10 Aug 2023 2 +$100,000 4 Director 30 Oct 2023, 21:51
ASPI ASP Isotopes Inc. 29 Jun 2023 2 +$49,990 4 Director 03 Jul 2023, 07:04
ASPI ASP Isotopes Inc. 18 May 2023 1 +$6,230 4 Director 19 May 2023, 16:05
ASPI ASP Isotopes Inc. 10 May 2023 1 +$5,000 4 Director 16 May 2023, 08:09
ASPI ASP Isotopes Inc. 06 Apr 2023 1 +$19,998 4 Director 11 Apr 2023, 10:50
ASPI ASP Isotopes Inc. 15 Nov 2022 1 $0 4 Director 16 Nov 2022, 11:41
ASPI ASP Isotopes Inc. 09 Nov 2022 0 $0 3 Director 14 Nov 2022, 15:40
ALLR Allarity Therapeutics, Inc. 20 Dec 2021 0 $0 3 Director 22 Dec 2021, 15:30